Forgot password? Don't have an account? Sign Up! Already have an account? Volcon, Inc. Announces Launch of Proposed Public Offering. The purchase was funded through convertible notes and partial monetization of its Monarch Medical Technologies investment. The company reported impressive BTC Yield metrics: The company's diluted shares outstanding increased to 11,, as of February 3, , compared to 8,, on June 30, , reflecting the impact of convertible notes and stock options.
Semler Scientific SMLR ha ampliato le proprie partecipazioni in bitcoin con l'acquisto di BTC per 88,5 milioni di dollari tra l'11 gennaio e il 3 febbraio Al 3 febbraio , SMLR detiene 3.
El precio promedio de compra fue de Al 3 de febrero de , SMLR posee 3. Januar und dem 3. Februar erweitert. Der Kauf wurde durch wandelbare Anleihen und eine teilweise Monetarisierung seiner Investition in Monarch Medical Technologies finanziert. Der durchschnittliche Kaufpreis betrug Januar bis 3. Februar auf Juni , was die Auswirkungen der wandelbaren Anleihen und Aktienoptionen widerspiegelt. Semler Scientific's aggressive bitcoin acquisition strategy marks a dramatic pivot for a healthcare technology company, raising several critical considerations for investors.
While showing an impressive The diluted share count has increased from 8,, to 11,, shares, representing a The monetization of their Monarch Medical Technologies investment to fund BTC purchases signals a concerning shift away from core operational assets.
This strategy introduces substantial cryptocurrency exposure risk to what was previously a pure-play healthcare technology investment. The company's bitcoin holdings now represent a significant portion of its market capitalization, fundamentally altering its risk profile. Three key risks demand investor attention: The company's core business focus may be compromised by this treasury strategy Significant shareholder dilution through convertible notes and potential future capital raises Extreme volatility exposure through concentrated bitcoin position.
